Arimidex, Anastrozole Newswire

Arimidex, Anastrozole Newswire

Comprehensive Real-Time News Feed for Arimidex, Anastrozole (generic).

Results 1 - 20 of 57 in Arimidex, Anastrozole (generic)

  1. HAVAH Therapeutics Release: 8th International Breast Densitometry...Read the original story

    Sunday Jun 25 | BioSpace

    MD PhD presented breakthrough findings into the reduction of mammographic breast density at the 8th International Breast Densitometry and Cancer Risk Assessment Conference in ; included presentations and posters by researchers from institutions across the world, including the, the Mayo Clinic and Queen Mary University of Dr. Birrell, Chief Medical Officer and founder of HAVAH Therapeutics was an invited speaker at the internationally attended conference at the forefront of research into improved breast cancer screening, risk assessment and preventative strategies.

    Comment?

  2. Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study Of Abemaciclib...Read the original story w/Photo

    Apr 23, 2017 | Drugs.com

    Eli Lilly and Company today announced that following a pre-planned interim analysis for MONARCH 3, the trial met its primary endpoint of demonstrating statistically significant improvement in progression-free survival . In addition, improvement was shown in a key secondary endpoint of objective response rate .

    Comment?

  3. Cancer Hormone Therapy Market - Worldwide Industry Analysis and Forecast 2015-2023Read the original story w/Photo

    Tuesday Jun 20 | SBWire

    Hormones are natural substances made by our glands in our body and the network of glands that make hormones is termed as endocrine systems. These hormones are carried through bloodstream and act as a messenger between one part to another part of our body.

    Comment?

  4. Lupron experiencesRead the original story w/Photo

    Jun 9, 2017 | Ask MetaFilter

    Has anyone had experience with Lupron. I'm curious as what to expect. I've read the literature, but first hand experiences would be great.

    Comment?

  5. Vaccine offers hope in treatment of breast cancerRead the original story w/Photo

    May 17, 2017 | Manawatu Evening Standard

    This weekend, my daughters and I will be cooking up a storm in the kitchen, hosting a Pink Ribbon brunch for friends. I am sure pink icing will be a big feature, with some rose-tinted bubbles for the mums.

    Comment?

  6. Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib...Read the original story w/Photo

    Apr 24, 2017 | PR Newswire

    The Phase 3 study compared abemaciclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in patients with HR+, HER2- advanced breast cancer /PRNewswire/ -- Eli Lilly and Company today announced that following a pre-planned interim analysis for MONARCH 3, the trial met its primary endpoint of demonstrating statistically significant improvement in progression-free survival . In addition, improvement was shown in a key secondary endpoint of objective response rate .

    Comment?

  7. Eli Lilly and Company logo.Read the original story w/Photo

    Apr 24, 2017 | PR Newswire

    In addition, improvement was shown in a key secondary endpoint of objective response rate . The Phase 3 study evaluated abemaciclib, a cyclin-dependent kinase 4 and CDK6 inhibitor, in combination with an aromatase inhibitor compared to treatment with an aromatase inhibitor alone in women with hormone-receptor-positive , human epidermal growth factor receptor 2-negative advanced breast cancer.

    Comment?

  8. Eli Lilly Finally Catches a Break With Encouraging Phase III Breast Cancer DataRead the original story

    Apr 23, 2017 | BioSpace

    Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis - The Phase 3 study compared abemaciclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in patients with HR+, HER2- advanced breast cancer /PRNewswire/ -- Eli Lilly and Company today announced that following a pre-planned interim analysis for MONARCH 3, the trial met its primary endpoint of demonstrating statistically significant improvement in progression-free survival . In addition, improvement was shown in a key secondary endpoint of objective response rate .

    Comment?

  9. Dozens under scrutiny for steroid useRead the original story w/Photo

    Apr 7, 2017 | The New Zealand Herald

    Dozens of sportsmen have been identified importing steroids into the country, creating a dilemma for anti-doping agency Drug Free Sport New Zealand. Most, if not all, of the cases are understood to involve people playing below elite level.

    Comment?

  10. Understanding and treating ER-positive breast cancerRead the original story w/Photo

    Apr 7, 2017 | Medical News Today

    Certain breast cancers occur as a direct result of the many hormone receptors on the surface of breast cells. These receptors are made up of proteins that accept hormones that tell the cell when to grow.

    Comment?

  11. NYSAC vague on drug-testing plan for Chael Sonnen, Wanderlei SilvaRead the original story w/Photo

    Mar 30, 2017 | MMAFighting.com

    The New York State Athletic Commission won't say directly whether Chael Sonnen and Wanderlei Silva will face out-of-competition testing ahead of Bellator's New York debut. Sonnen and Silva, who meet in the main event of Bellator 180 on June 24 at Madison Square Garden, are both coming off lengthy doping-related suspensions in Nevada.

    Comment?

  12. USADA issues one-year ban for UFC flyweight Matheus Nicolau following failed drug testRead the original story w/Photo

    Mar 30, 2017 | BloodyElbow

    UFC flyweight Matheus Nicolau was banned for one-year following a failed out-of-competition USADA test in October, which resulted in his removal from a UFC card in November. The official USADA press release has details on what the Brazilian tested positive for.

    Comment?

  13. UFC's Matheus Nicolau gets one-year suspension from USADA after testing positive for anastrozoleRead the original story w/Photo

    Mar 29, 2017 | MMAFighting.com

    The Brazilian fighter has received a one-year suspension by the UFC's anti-doping partner after testing positive for anastrozole, a prohibited substance in the category of Hormone and Metabolic Modulators that is at all times prohibited by the UFC Anti-Doping Policy. The news was announced by USADA on Wednesday, per a press release.

    Comment?

  14. Matheus Nicolau Latest UFC Fighter Suspended Under Anti-Doping PolicyRead the original story w/Photo

    Mar 29, 2017 | MMA Weekly

    The U.S. Anti-Doping Agency announced on Wednesday that UFC athlete Matheus Nicolau , of Belo Horizonte, Brazil, accepted a one-year sanction after testing positive for a prohibited substance. Nicolau, 24, tested positive for anastrozole following an out-of-competition urine test conducted on October 13, 2016.

    Comment?

  15. UFC Flyweight Matheus Nicolau Accepts 1-Year Suspension for Anti-Doping ViolationRead the original story w/Photo

    Mar 29, 2017 | Sherdog

    Matheus Nicolau Pereira has accepted a one-year suspension from USADA for a positive drug test stemming from an out-of-competition urine test on Oct. 13. USADA announced the sanction in a statement on Wednesday. Nicolau tested positive for anastrozole, which is listed in the category of hormone and metabolic modulators and is prohibited according to WADA code.

    Comment?

  16. Can we use gonadotropin plasma concentration as surrogate marker for...Read the original story w/Photo

    Mar 27, 2017 | BioMed Central

    BMI has been suggested to impact on estrogenic activity in patients receiving anastrozole resulting in a reduced treatment efficacy in obese women. Current evidence in this regard is controversially discussed.

    Comment?

  17. More than 1,100 medicines will have their prices cutRead the original story w/Photo

    Mar 24, 2017 | Daily Mail

    BREAKING NEWS: Three injured after Amtrak train with 250 passengers on board derails and slams into another train at New York's Penn Station in middle of rush hour 'We'll see what happens', shrugs Trump with hours to go till do-or-die Obamacare repeal vote - after he blasts GOP's gridlocking right-wingers She's about to be a millionaire, how bow dah? 'Cash me ousside' girl is set to make $1million off the back of her viral fame You've been microwaving leftovers wrong! Viral image reveals how to make sure your meals heat up evenly The hilarious moment a cop who was told he would be ARRESTED by an IRS scammer calls back the conman to expose the ruse Casey Anthony and OJ Simpson may star in joint reality show that reveals how they 'live with the crimes they were acquitted of' Two dead and more than a dozen injured after an 18-wheeler, a car and a bus carrying a high school track team ... (more)

    Comment?

  18. Unauthorized prescription drugs seized in Richmond may pose serious risks, Health Canada saysRead the original story w/Photo

    Mar 21, 2017 | CBC News

    Anastrozole from EPCA Shipping in Richmond, B.C. Health Canada says it seized several unauthorized prescription products from the company that could pose serious health risks to Canadians. Products seized from EPCA Shipping Inc. at 1115-11871 Horseshoe Way in Richmond B.C., which Health Canada says is the Canadian distribution centre for Extremepeptides.com, include drugs promoted to treat a wide variety of medical conditions.

    Comment?

  19. Abstract P124: Network Meta-analysis of the Effects of Breast Cancer...Read the original story

    Mar 7, 2017 | Circulation

    Introduction: Adjuvant hormone therapy prolongs survival of patients with early-stage hormone receptor-positive breast cancer . For postmenopausal patients, aromatase inhibitors have been shown to improve disease free survival compared to tamoxifen, but the impact on overall survival has been inconsistent.

    Comment?

  20. North Korea fires 4 ballistic missiles, Japan calls it 'extremely unsafe action'Read the original story

    Mar 6, 2017 | The Oak Ridge Observer

    "It will take a while before we can come up with a final analysis ", the JCS said. Earlier in the day, military officials raised the possibility that the projectiles could be ICBMs if launched at a high angle.

    Comment?